Search the Newsreel

Upbound's Brigit Revenue Rises 37% to $71M as Subscribers Grow

Upbound Group Inc. announced its second-quarter 2026 results, with consolidated revenue reaching approximately $1.2 billion. The Brigit segment experienced significant growth, with revenue increasing 37% year-over-year to $71 million, driven by a 30% rise in paying subscribers. The company also reaffirmed its full-year 2026 …

Upbound Group Inc (UPBD) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Upbound Group Inc (UPBD), noting its current valuation score of 7.88, ranking 55th in the Specialty Retailers industry. It highlights the company's current P/E ratio of 14.20, comparing

Upbound Group (NASDAQ:UPBD) Issues FY 2026 Earnings Guidance

Upbound Group (UPBD) Earnings Date and Reports 2026

Upstream Bio Inc (UPB) Financial Health: Profitability & Balance Sheet Analysis

Upstream Bio Inc (UPB) has a current financial score of 7.08, placing it 156th out of 384 companies in the Biotechnology & Medical Research industry, indicating a robust financial status but low operating efficiency. The company's latest quarterly revenue saw an 82.69% year-over-year increase, …

Upbound Group Data Breach: Investigation Ongoing

Upbound Group Inc. has disclosed a cybersecurity incident where unauthorized actors accessed non-sensitive customer information, leading to the fraudulent creation of lease-to-own agreements. The breach was reported to the SEC on July 21, 2026, and details were publicly posted on July 23, 2026. Upbound …

Upbound Group, Inc. (UPBD) Q4 2025 Earnings Report - Results, Call & Slides

Upbound Group, Inc. (UPBD) reported its Q4 2025 earnings, achieving Actual EPS of $17.62 against a consensus of $16.97, beating expectations by $0.65

Upstream Bio Inc (UPB) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Upstream Bio Inc (UPB), noting its current valuation score of 8.10 within the Biotechnology & Medical Research industry. It details UPB's P/E ratio, highlighting its position relative to recent highs and lows. The analysis also states that …

Altshuler Shaham Ltd Reduces Position in Upstream Bio, Inc. $UPB

Upstream Bio (UPB) Expected to Release Quarterly Earnings on Wednesday

Upbound Group Number of Employees 2026 | Employee Count & Headcount Data

Upbound Group, Inc. (UPBD) had approximately 12,035 total employees worldwide as of March 2026, a 4.4% decline from 2023. The company is actively hiring, with 1,377 active job postings in 2026, a 32.7% increase from 2025. Upbound Group's workforce is concentrated in the United …

Upstream Bio Inc (UPB) Cash Flow

This article provides a detailed cash flow statement for Upstream Bio Inc (UPB), covering quarterly and annual data for operating, investing, and financing activities. It presents key financial figures such as net income, capital expenditures, and free cash flow, along with year-over-year percentage changes. …

UPB|Upstream Bio Inc|Price:6.400|Chg%:-0.010

Upstream Bio Inc. (UPB) is a clinical-stage biotechnology company focused on developing treatments for inflammatory diseases, specifically severe respiratory disorders. The company's primary candidate, verekitug, targets the TSLP receptor and is currently in Phase II trials for severe asthma and chronic rhinosinusitis with nasal …

UPBD|Upbound Group Inc|Price:20.460|Chg%:-0.620

This article provides a detailed company profile for Upbound Group Inc (UPBD), a technology and data-driven financial products company. It outlines the company's customer-facing brands like Rent-A-Center, Brigit, and Acima, along with key financial data, market performance, and executive information. The piece also includes …

Upbound Group Inc (UPBD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Upbound Group Inc (UPBD) by business segment and geographical region. It shows that Store-Rentals And Fees constitute the largest portion of revenue at 77.25%, with the United States generating the vast majority of regional revenue at …

Upstream Bio Inc (UPB) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey provides a revenue breakdown for Upstream Bio Inc (UPB), though notes that detailed segment and profit contribution data have not yet been disclosed by the company. It highlights that the company's reported revenue of $2.85 million originates entirely from the …

Upbound Group Inc (UPBD) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Upbound Group Inc (UPBD), highlighting its current earnings forecast score, average price target, and analyst ratings. It indicates that the company ranks 10 out of 93 in the Specialty Retailers industry with an average price target of …

Upstream Bio Inc (UPB) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Upstream Bio Inc (UPB), identifying major institutional holders and their respective proportions. It breaks down shareholder types, institutional shareholding trends over several quarters, and recent shareholder activity including changes in holdings. Additionally, it lists ETFs with exposure …

Upbound Group Inc (UPBD) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides a historical overview of dividend payouts and stock split events for Upbound Group Inc (UPBD). It details dividend information including ex-dividend dates, record dates, payment dates, and the gross cash dividend amount per share for various periods, showing a consistent payout …

Upbound Group, Inc. Revenue Breakdown – TRADEGATE:RAC

Upbound Group, Inc. reported a total revenue of €4.00 billion last year, with its top-performing segment, Acima, contributing €2.14 billion. The United States was the largest geographical contributor, accounting for €3.93 billion of the revenue. These figures show a slight decrease from the previous …

TradingKey

This article provides a detailed quarterly and annual income statement for Upstream Bio Inc (UPB), covering various financial metrics such as revenue, operating expenses, net income, and EPS. It also includes an FAQ section explaining how to interpret income statements and highlighting key financial …

Is Upbound Group (UPBD) A Bargain Following Its Recent Share Price Pullback?

Upbound Group (UPBD) has experienced mixed stock performance, with a recent pullback despite yearly gains, raising questions about its current valuation. The company is considered 28.2% undervalued by a narrative fair value framework, driven by expected revenue growth from new credit offerings and merchant …

News - Upbound Group says data breach fueled $13 million in fraudulent leases

Upbound Group, Inc. disclosed that a data breach led to approximately $13 million in fraudulent contract losses within its Acima segment during the second quarter of 2026. Non-sensitive customer information and documents obtained during the cybersecurity incidents were used to set up fraudulent lease-to-own …

Hsbc Holdings PLC Makes New $5.76 Million Investment in Upstream Bio, Inc. $UPB

Upbound Group Says Data Breach Led to $13 Million in Fraudulent Contract Losses

Upbound Group, a Texas-based consumer finance company, reported that a recent data breach led to approximately $13 million in fraudulent contract losses in its Acima segment during the second quarter of 2026. Hackers obtained non-sensitive customer information, which was then used to facilitate fraudulent …

Decheng Capital LLC Sells 418,210 Shares of Upstream Bio, Inc. $UPB

Upbound Group (UPBD) investor Aaron Allred discloses 3.1% beneficial stake in 13G/A

Aaron Allred has disclosed a 3.1% beneficial ownership stake in Upbound Group, Inc. (UPBD) through a Schedule 13G/A filing. His ownership totals 1,821,642 shares held across two LLCs, Alterra Holdings and Arklow Holdings, giving him sole or shared voting and dispositive power. This stake …

Upbound reports ~$13M fraudulent losses in Acima after data compromise

Upbound disclosed cybersecurity incidents that have resulted in approximately $13 million in fraudulent contract losses within its Acima segment for Q2 2026. Non-sensitive customer data was compromised and used to create fraudulent lease-to-own agreements. The company has implemented stronger authentication and enhanced fraud detection …

SEB Asset Management AB Buys New Stake in Upstream Bio, Inc. $UPB

Enterprise value to revenue forward of Upstream Bio, Inc. – NASDAQ:UPB

This article focuses on the enterprise value to revenue forward metric for Upstream Bio, Inc. (NASDAQ: UPB). It provides a snapshot of this financial ratio sourced from TradingView, indicating the value and any changes over a given period. The content is presented within the …

Upstream Bio (Nasdaq:UPB) - Stock Analysis

Upstream Bio (Nasdaq:UPB) is a clinical-stage biotechnology company focused on treating inflammatory diseases, particularly severe respiratory disorders, with its lead asset verekitug. The company recently presented positive Phase 2 data for verekitug in chronic rhinosinusitis with nasal polyps (CRSwNP) and severe asthma, demonstrating clinically …

ETFs Investing in Upstream Bio, Inc. Stocks

This article lists various ETFs that hold shares of Upstream Bio, Inc. (UPB), providing details such as market value, weight in the ETF, issuer, management style, expense ratio, AUM, price, and performance metrics. The information aims to help investors identify funds that offer exposure …

Upbound Group, Inc. Announces Timing of Second Quarter 2026 Financial Results

Upbound Group, Inc. (NASDAQ: UPBD) announced that it will release its second-quarter 2026 financial results before the market opens on July 30, 2026. A conference call will follow at 9:00 a.m. ET to discuss the results, with a live webcast available for interested parties. …